MDP.TO
Medexus Pharmaceuticals Inc
Price:  
3.05 
CAD
Volume:  
21,000.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MDP.TO WACC - Weighted Average Cost of Capital

The WACC of Medexus Pharmaceuticals Inc (MDP.TO) is 8.5%.

The Cost of Equity of Medexus Pharmaceuticals Inc (MDP.TO) is 10.95%.
The Cost of Debt of Medexus Pharmaceuticals Inc (MDP.TO) is 6.90%.

Range Selected
Cost of equity 9.30% - 12.60% 10.95%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 6.30% - 7.50% 6.90%
WACC 7.4% - 9.7% 8.5%
WACC

MDP.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 1.2 1.38
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.30% 12.60%
Tax rate 25.90% 26.50%
Debt/Equity ratio 0.7 0.7
Cost of debt 6.30% 7.50%
After-tax WACC 7.4% 9.7%
Selected WACC 8.5%